A Journey Into Participation Patterns Among Patients With Hidradenitis Suppurativa
Not yet recruiting
- Conditions
- Hidradenitis Suppurativa
- Registration Number
- NCT06201858
- Lead Sponsor
- Power Life Sciences Inc.
- Brief Summary
This study aims to uncover the factors driving patient decisions regarding enrollment, withdrawal, or re-engagement in hidradenitis suppurativa clinical trials. Understanding these factors will significantly improve the relevance and effectiveness of future research endeavors.
Ultimately, this trial endeavors to deepen our understanding of the factors impacting hidradenitis suppurativa clinical trial participation. Enhancing participation rates could accelerate the development of innovative treatments for this debilitating condition.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 500
Inclusion Criteria
- Aged ≥ 18 years old
- Diagnosis of hidradenitis suppurativa
- Able to comprehend the investigational nature of the protocol and provide informed consent
Exclusion Criteria
- Female patients who are currently pregnant or nursing
- Inability to perform regular electronic reporting
- Has known psychiatric or substance abuse disorders that would interfere with cooperation with the requirements of the trial.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Number of hidradenitis suppurativa patients who decide to enroll in a clinical research 3 months Rate of hidradenitis suppurativa patients who remain in clinical trial to trial completion 12 months
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Power Life Sciences
🇺🇸San Francisco, California, United States
Power Life Sciences🇺🇸San Francisco, California, United StatesMichael B GillContact415-900-4227https://www.withpower.com/contact-us@withpower.com